MBAI 1-for-7 reverse split effective as merger with MBody AI moves toward Nasdaq listing
AI Summary
Check‐Cap (MBAI) implemented a 1-for-7 reverse share split effective Aug 13, 2026, reducing outstanding shares from ~9.46M to ~1.35M and trading on a split-adjusted basis under the MBAI ticker. The split is a shareholder-approved step to position the combined company to meet Nasdaq's $4.00 minimum bid for an initial listing as Check‐Cap advances its merger with MBody AI, which the company says remains on track to close in Q3 2026 pending final Nasdaq approval and customary closing conditions. Timing: Same-day dilution is possible only if the company starts sales under the facility, and the press release does not say when that could happen.
Positives
- 1-for-7 reverse split effective Aug 13, 2026; issued shares adjusted to ~1,351,866 and trading adjusted under MBAI
- Company says the split is intended to help the combined entity meet Nasdaq's $4.00 minimum bid requirement for initial listing
- Company states the proposed merger with MBody AI remains on track to close in Q3 2026
Negatives
- Merger and Nasdaq initial listing remain subject to final Nasdaq approval and customary closing conditions, none of which is assured
- Reverse split reduces share count and may lower liquidity and increase post-split price volatility
Filing Context
Filing and Dilution Context
Earliest dilution
Earliest dilution: after company starts sales
Dilution status
conditional
Dilution timing
Dilution status: Undetermined
Trigger type
purchase_trigger